Temaz and Zolmitriptan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Zolmitriptan (zolmitriptan). Common drug interactions include serotonin syndrome among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Zolmitriptan. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Zolmitriptan?

Zolmitriptan has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 2,568 Zolmitriptan users. Check the latest studies of Zolmitriptan.



On Jul, 07, 2026

19 people who take Temaz and Zolmitriptan together, and have interactions are studied.

Temaz and Zolmitriptan drug interactions.

What are the common drug interactions of Temaz and Zolmitriptan, by gender? *:

female:

  1. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  2. Hyperammonaemia
  3. Abdominal injury
  4. Abdominal pain
  5. Adverse event
  6. Agitation (state of anxiety or nervous excitement)
  7. Anxiety
  8. Arthralgia (joint pain)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Bipolar disorder (mood disorder)

male:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Abdominal pain
  3. Diarrhoea haemorrhagic (bloody diarrhoea)
  4. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  5. Enteritis (inflammation of the small intestine)
  6. Gastrointestinal motility disorder (abnormal intestinal contractions)
  7. General physical health deterioration (weak health status)
  8. Haematochezia (passage of stools containing blood)
  9. Haematocrit decreased
  10. Haemoglobin decreased

What are the common drug interactions of Temaz and Zolmitriptan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Headache (pain in head)
  2. Infusion site swelling
  3. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  4. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  5. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  6. Nausea (feeling of having an urge to vomit)
  7. Throat irritation

50-59:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Abdominal pain
  3. Diarrhoea haemorrhagic (bloody diarrhoea)
  4. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  5. Enteritis (inflammation of the small intestine)
  6. Gastrointestinal motility disorder (abnormal intestinal contractions)
  7. General physical health deterioration (weak health status)
  8. Haematochezia (passage of stools containing blood)
  9. Haematocrit decreased
  10. Haemoglobin decreased

60+:

n/a

What are the existing conditions these people have? *

  1. Depression: 5 people, 26.32%
  2. Immunodeficiency Common Variable: 4 people, 21.05%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 15.79%
  4. Psoriasis (immune-mediated disease that affects the skin): 3 people, 15.79%
  5. Pain: 3 people, 15.79%
  6. Nausea (feeling of having an urge to vomit): 3 people, 15.79%
  7. Myoclonic Epilepsy (type of epilepsy with quick little jerks of the arms, shoulder, or occasionally the legs): 3 people, 15.79%
  8. Bipolar Disorder (mood disorder): 1 person, 5.26%
  9. Asthma: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Zolmitriptan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temaz and Zolmitriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zolmitriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zolmitriptan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and zolmitriptan (the active ingredients of Temaz and Zolmitriptan, respectively), and Temaz and Zolmitriptan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: